Pharma China

 Access to the biggest consumer market.

Pharma China Consulting was founded in 2017 in Germany, is a professional insider for license in/out business for China, USA, EU and all over the world with 150 years common experience.

As a Pharma/Biotech consulting company based in Munich Germany we are serving our clients in China, USA, EU to build trust and work together for a long term win-win.

Main Sector: Professional Services and Consulting

Subsector(s): Business development, Deal arrangment, Event organization, Market Research

Primary therapeutic area(s):  Cardiovascular, Congenital malformations, deformations and chromosomal abnormalities, Digestive system, Diseases of the blood and blood-forming organs; immune disorders, Diseases of the ear, Diseases of the eye, Diseases of the nervous system, Endocrine, nutritional and metabolic diseases, External causes of morbidity and mortality, Mental and behavioural disorders

Partnering strategy / collaborations

We solve problems for our clients. Our strengths are communications across cultures and deep understanding of the need of our partners.

Client portfolio 

Reneo Pharma (USA),   Fidia (Italy), Neuraxpharma (Spain), Welding (Germany), Winhealth (Hong Kong), China Resource(China),  Hemony (China), Hisun (China), Hasten Pharma (China), Auzone Biotech, Farmamondo (Switzerland), APR(Switzerland) ......

Another Milestone: License in China of AFT Pharmaceulicals

find out more at below link

https://investors.aftpharm.com/DownloadFile.axd?file=Announcements/NZX/20240930/428359.pdf